Devgen delisted from NYSE Euronext Brussels
Belgian biotechnology company Devgen has been delisted from the NYSE Euronext Brussels exchange. The move is part of Syngenta’s acquisition bid for Devgen, which began in September last year ( Agrow No 653, p 2). Following the acquisition of 98.3% of shares in January, Syngenta opened a squeeze-out that closed on February 26th. The results of the squeeze-out will be announced on March 5th and payment of the shares and warrants tendered during the squeeze-out will take place on March 8th. Syngenta will hold 100% of the Devgen shares upon the closing and settlement of the squeeze-out.